The Food and Drug Administration (FDA), a US federal agency is approving two antimalarial drugs for coronavirus treatment, President Donald Trump said on Thursday.
According to the president, the two antimalarial drugs, undergoing approval include; hydroxychloroquine and Gilead's remdesivir.
L
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
